(Q51666343)

9 April 2018

title

Inhalation efficacy of RFI-641 in an African green monkey model of RSV infection (English)

1 reference

9 April 2018

author name string

Weiss WJ

1

1 reference

9 April 2018

Murphy T

2

1 reference

9 April 2018

Lynch ME

3

1 reference

9 April 2018

Frye J

4

1 reference

9 April 2018

Buklan A

5

1 reference

9 April 2018

Gray B

6

1 reference

9 April 2018

Lenoy E

7

1 reference

9 April 2018

Mitelman S

8

1 reference

9 April 2018

O'Connell J

9

1 reference

9 April 2018

Quartuccio S

10

1 reference

9 April 2018

Huntley C

11

1 reference

9 April 2018

publication date

1 April 2003

1 reference

9 April 2018

Journal of Medical Primatology

published in

1 reference

9 April 2018

volume

32

1 reference

9 April 2018

issue

2

1 reference

9 April 2018

page(s)

82-88

1 reference

9 April 2018

Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0684.2003.00014.X

Mouse model of respiratory syncytial virus infection to evaluate antiviral activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0684.2003.00014.X

Novel and specific respiratory syncytial virus inhibitors that target virus fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0684.2003.00014.X

7 January 2021

Aerosol treatment of respiratory viral disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0684.2003.00014.X

7 January 2021

Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0684.2003.00014.X

7 January 2021

Clinical profile of pediatric patients hospitalized with respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0684.2003.00014.X

7 January 2021

Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0684.2003.00014.X

7 January 2021

Recent progress in antiviral chemotherapy for respiratory syncytial virus infections

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0684.2003.00014.X

7 January 2021

Respiratory syncytial virus infection in immunosuppressed animals: implications in human infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0684.2003.00014.X

7 January 2021

Respiratory syncytial virus (RSV) disease and prospects for its control

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0684.2003.00014.X

7 January 2021

CL387626 exhibits marked and unusual antiviral activity against respiratory syncytial virus in tissue culture and in cotton rats

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0684.2003.00014.X

7 January 2021

10.1034/J.1600-0684.2003.00014.X

Identifiers

DOI

1 reference

9 April 2018

1 reference

9 April 2018